Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Indian Journal of Surgery|March 25, 2016
Unusual Parapharyngeal Space NeoplasmsAkshat Malik, Poonam Joshi, Harsh Thanky, et al.
South Asian Journal of Cancer|October 5, 2017
Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern IndiaRudresha Antapura Haleshappa, Aditi Harsh Thanky, Lakshmaiah Kuntegowdanahalli, et al.
South Asian Journal of Cancer|February 7, 2018
Prognostic significance of bone only metastasis compared to visceral metastasis in patients with carcinoma cervix treated with platinum-based chemotherapySuresh Babu Mallekavu, Aditi Harsh Thanky, Govind Babu Kanakasetty, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 17, 2016
Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern IndiaGovind Babu Kanakasetty, Lakshmaiah Kuntejowdahalli, Aditi Harsh Thanky, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2017
Can the Use of Bone Marrow Parameters Improve the Efficacy of Risk Prediction Scores in Chronic Myeloid Leukemia in Imatinib Era?Govind Babu Kanakasetty, Aditi Harsh Thanky, Lakshmaiah Kuntegowdanahalli, et al.
The Gulf Journal of Oncology|October 12, 2017
Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern IndiaK C Lakshmaiah, Aditi Harsh Thanky, D Lokanatha, et al.
Ecancermedicalscience|December 1, 2016
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern IndiaLakshmaiah Chinnagiriyappa Kuntegowdanahalli, Govind Babu Kanakasetty, Aditi Harsh Thanky, et al.
JCO Global Oncology|November 19, 2025
Practice Patterns and Outcomes in Advanced Colorectal Cancers From a Multi-Institutional Analysis: Real-World Evidence From IndiaAnant Ramaswamy, Ramjas Prajapati, Vivek Agarwala, et al.
Cancer|June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
Pageof 1